A long-term administration trial of SEP-363856 in patients with schizophrenia

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2025
This article has no abstract
Epistemonikos ID: 7dcd91f9af57095dafdd18d4916f3ec41c8860fd
First added on: Apr 24, 2026